Calamos Advisors
ORGO icon

Calamos Advisors’s Organogenesis Holdings ORGO Stock Holding History

Calamos Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-218,895
Closed -$3.12M – 1150
2021
Q3 		$3.12M Buy
218,895
+32,508
+17% +$505K 0.01% 707
2021
Q2 		$3.1M Buy
186,387
+122,292
+191% +$2.28M 0.01% 650
2021
Q1 		$1.17M Buy
+64,095
New +$868K 0.01% 754

Other funds holding ORGO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Calamos Advisors's ORGO Position: Q4 2021 in Review

Calamos Advisors sold out of Organogenesis Holdings (ORGO) in Q4 2021, closing a stake of 218,895 shares — an estimated $3.12M sold.

Calamos Advisors first reported a position in ORGO in Q1 2021 and held it in 3 quarters. The position peaked at $3.12M in Q3 2021. 157 funds tracked by Wall St. Rank hold ORGO as of Q4 2021.

  • Calamos Advisors reported no remaining Organogenesis Holdings position as of Q4 2021 after selling out during the quarter.
  • Calamos Advisors sold 218,895 Organogenesis Holdings shares in Q4 2021, an estimated $3.12M.
  • Calamos Advisors first reported a position in Organogenesis Holdings in Q1 2021 and held it in 3 quarters.
  • Calamos Advisors's Organogenesis Holdings position peaked at $3.12M in Q3 2021.
  • 157 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2021.

Based on Calamos Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.